Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 68,673 | 67,246 | 61,775 | 59,486 | 52,506 |
| Cost of Goods | 16,732 | 16,195 | 15,058 | 13,421 | 11,364 |
| Gross Profit | 51,941 | 51,051 | 46,717 | 46,065 | 41,142 |
| Operating Expenses | 40,533 | 40,014 | 37,510 | 36,644 | 33,001 |
| Operating Income | 12,140 | 11,232 | 9,265 | 9,842 | 8,505 |
| Interest Expense | 0 | 0 | 0 | 1 | 0 |
| Other Income | -513 | -1 | 149 | -138 | 525 |
| Pre-tax Income | 11,627 | 11,231 | 9,414 | 9,703 | 9,030 |
| Income Tax | 3,631 | 3,818 | 3,201 | 2,866 | 2,974 |
| Net Income Continuous | 7,996 | 7,413 | 6,213 | 6,837 | 6,056 |
| Net Income | $7,996 | $7,413 | $6,213 | $6,837 | $6,056 |
| EPS Basic Total Ops | 0.21 | 0.20 | 0.16 | 0.18 | 0.16 |
| EPS Basic Continuous Ops | 0.21 | 0.19 | 0.16 | 0.18 | 0.16 |
| EPS Diluted Total Ops | 0.20 | 0.18 | 0.15 | 0.17 | 0.14 |
| EPS Diluted Continuous Ops | 0.20 | 0.18 | 0.15 | 0.16 | 0.14 |
| EBITDA(a) | $13,315 | $12,461 | $10,291 | $10,880 | $9,505 |